Labcyte Advances Automatic Acoustic Liquid Handling With Dynamic Fluid Analysis™

Labcyte has patented and released a novel software algorithm that enables a greater range of fluid types to be automatically transferred with acoustic energy. Dynamic Fluid Analysis enables the Echo® liquid handling systems to adapt to fluid properties changes such as surface tension and viscosity, and adjusts sound energy in real time with no operator intervention required. The advanced capabilities eliminate the operator calibration required by other liquid handling devices.

February 06, 2012
Sunnyvale, CA
Sunnyvale, CA, February 6, 2012 –Labcyte has patented and released a novel software algorithm that enables a greater range of fluid types to be automatically transferred with acoustic energy. Dynamic Fluid Analysis™ enables the Echo® liquid handling systems to adapt to fluid properties changes such as surface tension and viscosity, and adjusts sound energy in real time with no operator intervention required. The advanced capabilities eliminate the operator calibration required by other liquid handling devices.

Echo liquid handling systems use ultrasound energy to transfer samples and reagents in a completely tipless and touchless manner. Dynamic Fluid Analysis interrogates solutions in real time on a well-by-well basis ensuring that a wide range of fluid types—cell lysates, varying reagent concentrations, proteins, and DNA—are transferred with the highest levels of precision and accuracy. Dynamic Fluid Analysis greatly enhances the Echo platform’s ability to adjust and compensate for inherent variations in fluids. With traditional liquid handling, operators are required to calibrate the machine in advance—a time-consuming process that is at best an approximation for conditions that may vary throughout an experimental assay. Errors in dispense parameters may lead to false results in an assay, resulting in costly experimental repeats or missed valuable results.

“Dynamic Fluid Analysis is a fundamental change in the way life science researchers will approach liquid handling,” stated Mark Fischer-Colbrie, Labcyte CEO. “Labcyte customers have demonstrated greatly improved miniaturized assays across a wide range of applications including qPCR, protein crystallography, and cell-based assays. Many applications require the precise transfer of viscous or low surface tension fluids, which are a challenge for other liquid handlers, especially in smaller formats. The Echo platform not only transfers these challenging solutions, but does so automatically.”

Dynamic Fluid Analysis is immediately available for all new Echo liquid handling platforms and will be demonstrated at the SLAS2012 meeting on February 6-7, 2012, in San Diego, California. Several posters and presentations at the conference will highlight the use and benefits of the advancement.

About Labcyte Inc.
Labcyte, a global life science instrumentation company, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids. The environmentally‐friendly Echo platform generates better results with significantly lower costs when compared to traditional liquid handling systems that have high running costs, are prone to transfer errors, risk sample contamination and waste large amounts of plastic lab consumables. Labcyte instruments are used worldwide by all of the top ten pharmaceutical companies, as well as by small to mid‐size pharmaceutical companies, biotechnology firms, contract research organizations and academic institutions. Our customers work across a wide spectrum of biology including drug discovery, genomics, proteomics, diagnostics, imaging mass spectrometry and live cell transfer. Labcyte, headquartered in Sunnyvale, California, has global sales and support. Labcyte has 46 U.S., 10 European, 5 Japanese and 1 Chinese patents with additional U.S. and international filings. For more information, visit www.labcyte.com.